University of Hamburg at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University of Hamburg brings 2 presentations to ESGCT 2026 in Hamburg, its home city. Its work centres on suppressor transfer RNA that reads through nonsense mutations to restore full-length protein in inherited disease. A particular combination of nucleotide modifications improves how well that approach recovers CFTR function.

OrganizationESGCT 2026 Attendance
University of Hamburg
Hamburg, Germany
Universities & institutes
Public research university in Hamburg, Germany.
Chair
Tue Oct 27
2:00pm–4:30pm
SESSION 1: ESGCT 2026 Opening: Clinical applications of gene therapy
with Tigem, Fraunhofer Institute for Cell Therapy and Immunology (IZI)
Clinical trials and translation
Poster
Wed Oct 28
1:30pm–3:30pm
Suppressor tRNA expression systems for restoration of full-length protein in inherited genetic diseases caused by nonsense mutations
AAVs / non integrative vectors
Talk
Thu Oct 29
10:00am–10:30am
A unique combination of nucleotide modifications enhances sup-tRNA efficacy in restoring CFTR function
SESSION 7d: Skin, pulmonary and skeletal diseases
RNA and oligonucleotide therapiesRare and inherited disease

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Hamburg

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction